IMS Health expands with SDI Health acquisition
NEW YORK — Healthcare market research firm IMS Health will buy privately held market research firm SDI Health, IMS said.
Terms of the transaction were not disclosed, but the deal would bring together two of the leading healthcare analytics companies. In terms of drug industry analytics, IMS focuses on drug sales and dispensed prescriptions, while SDI provides data on prescriptions written by physicians and other prescribers.
IMS, which has existed for more than 55 years and operates in more than 100 countries, said the acquisition would enable more robust patient and specialty analytics while allowing it to reach out to a broader set of stakeholders.
Transcept seeks regulatory approval for Intermezzo
POINT RICHMOND, Calif. — Transcept Pharmaceuticals has resubmitted its regulatory application for a drug to treat insomnia to the Food and Drug Administration, following a previous denial of approval by the agency, the drug maker said Tuesday.
Transcept sent in its application for Intermezzo (zolpidem tartrate), a pill placed under the tongue for treating patients who awake in the middle of the night and have difficulty falling asleep again.
In October 2009, the company received a complete response letter from the FDA, and the resubmission contains additional clinical study data.
NACDS Foundation unveils pharmacy scholarships
ALEXANDRIA, Va. — A total of 58 pharmacy school students from 39 colleges and schools of pharmacy have been awarded scholarships by the National Association of Chain Drug Stores Foundation, the group announced Tuesday.
The scholarships are valued at a total of $190,000. Money to fund the scholarship program comes from NACDS member and associate member companies that support the concept of pharmacy education, and is handed out to each of the nation’s more than 90 schools of pharmacy via a drawing held during the NACDS Annual Meeting each spring.
“As a pharmacist, it is an honor to award these scholarships to deserving pharmacy students,” said NACDS Foundation president Edith Rosato. “These students embody the hopes and dreams of every pharmacist and are a testament to the future health and well-being of patients they will serve."
“Congratulations to the scholarship winners, and thank you to the generous benefactors and supporters of the NACDS Foundation,” Rosato concluded.
Among the 58 winners are eight “exceptional” students receiving “named” scholarships, NACDS said. Those eight scholarships were created to honor distinguished pharmacy leaders and companies “that share the NACDS Foundation’s commitment to education, research and charitable work,” the group said today in a statement.
The eight top winners include:
Erin Coughlin of Northeastern University School of Pharmacy, Bouvé College of Health Sciences, and Daniel Salzwedel of the University of Wisconsin-Madison School of Pharmacy, who each received the Leonard J. DeMino Pharmacy Student scholarships;
Gabriella Blyumin of Nova Southeastern University College of Pharmacy, and Lisa Dertinger of the North Dakota State University College of Pharmacy, Nursing and Allied Sciences, received the Edmond Fougera Scholarships;
Thanh-Tam Le of the University of California, San Francisco School of Pharmacy, and Marisa Sochacki of the University of Toledo College of Pharmacy, received the Taro Research Foundation Scholarships; and
Justin Balint of Wilkes University Nesbitt School of Pharmacy, and Tamkeen Quraishi of the University of New England College of Pharmacy, were awarded the Teva Pharmaceuticals Robert J. Bolger scholarships.